256 related articles for article (PubMed ID: 12127665)
1. Multiple sclerosis and interferon beta-1b, past, present and future.
Horowski R
Clin Neurol Neurosurg; 2002 Jul; 104(3):259-64. PubMed ID: 12127665
[No Abstract] [Full Text] [Related]
2. The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.
Rice G
Arch Neurol; 2001 Aug; 58(8):1297-8. PubMed ID: 11493173
[No Abstract] [Full Text] [Related]
3. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
Petkau J; White R
Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643
[No Abstract] [Full Text] [Related]
4. Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b.
Frese A; Bethke F; Lüdemann P; Stögbauer F
Neurology; 1999 Nov; 53(8):1892-3. PubMed ID: 10563657
[No Abstract] [Full Text] [Related]
5. Editorial commentary to Narayanan et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.
Matthews PM
J Neurol; 2001 Nov; 248(11):987. PubMed ID: 11757964
[No Abstract] [Full Text] [Related]
6. Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
Khoury SJ; Weiner HL
Arch Intern Med; 1998 Mar; 158(6):565-73. PubMed ID: 9521220
[TBL] [Abstract][Full Text] [Related]
7. Rebif offers another option for treating multiple sclerosis.
Ryan M
J Am Pharm Assoc (Wash); 2002; 42(6):889-91. PubMed ID: 12482017
[No Abstract] [Full Text] [Related]
8. The role of interferons in the treatment of multiple sclerosis.
Kelley CL
J Neurosci Nurs; 1996 Apr; 28(2):114-20. PubMed ID: 8718760
[TBL] [Abstract][Full Text] [Related]
9. Treatment of multiple sclerosis with interferon beta 1b.
Dhib-Jalbut S; McFarland HF
Baillieres Clin Neurol; 1997 Oct; 6(3):467-80. PubMed ID: 10101584
[TBL] [Abstract][Full Text] [Related]
10. Interferon beta 1a.
Pozzilli C; Koudriavtseva T
Baillieres Clin Neurol; 1997 Oct; 6(3):481-93. PubMed ID: 10101585
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of multiple sclerosis. Consensus and controversies].
Hohlfeld R
Nervenarzt; 1999 Apr; 70(4):297. PubMed ID: 10354989
[No Abstract] [Full Text] [Related]
12. New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson.
Alsalameh S; Manger B; Kern P; Kalden J
Arthritis Rheum; 1998 Apr; 41(4):754. PubMed ID: 9550494
[No Abstract] [Full Text] [Related]
13. To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes.
Frohman EM; Racke M; van Den Noort S
Arch Neurol; 2000 Jul; 57(7):930-2. PubMed ID: 10891973
[No Abstract] [Full Text] [Related]
14. Experiences with interferon-beta-1b treatment in MS after three year follow-up.
Bencsik K; Rajda C; Füvesi J; Járdánházy T; Török M; Vécsei L
Swiss Med Wkly; 2002 May; 132(17-18):237. PubMed ID: 12087490
[No Abstract] [Full Text] [Related]
15. Treatment of multiple sclerosis with interferon beta-1 b.
Abdul-Ahad A; Shah S; Galazka A
Neurology; 1997 Aug; 49(2):641-2. PubMed ID: 9270626
[No Abstract] [Full Text] [Related]
16. Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients.
Morra VB; Coppola G; Orefice G; De Michele G; Vacca G; Filla A; Bonavita V
Neurology; 2004 Mar; 62(5):829-30. PubMed ID: 15007146
[No Abstract] [Full Text] [Related]
17. [Beta-interferon neutralizing antibodies. Do they have clinical value in patients with multiple sclerosis?].
Romero López J; Maciñeiras Montero JL
Med Clin (Barc); 2005 Feb; 124(4):144-5. PubMed ID: 15713245
[No Abstract] [Full Text] [Related]
18. Interferon-beta1b for the treatment of multiple sclerosis.
Lam S; Wang S; Gottesman M
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1111-7. PubMed ID: 18680445
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].
Demina TL; Khachanova NV; Davydovskaia MV; Popova NF; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):24-6. PubMed ID: 18567192
[No Abstract] [Full Text] [Related]
20. Interferon beta treatment in relapsing-remitting multiple sclerosis. A review.
Grigoriadis N
Clin Neurol Neurosurg; 2002 Jul; 104(3):251-8. PubMed ID: 12127664
[No Abstract] [Full Text] [Related]
[Next] [New Search]